What is the “Lipitor expiration date” critics are talking about?
People usually mean one of two timelines when they say “Lipitor expiration date”:
1) when atorvastatin (Lipitor) patents stopped blocking generic competition, and
2) when the drug’s exclusivity ended so lower-cost versions could be marketed.
Because the phrasing “criticsl” is unclear, the most likely intent is: when did Lipitor’s patent/exclusivity expire and generics begin to be sold widely.
When did Lipitor’s patent/exclusivity effectively end for generics?
Lipitor (atorvastatin) faced multiple patent and regulatory protection events over the years. Those protections do not expire all at once; instead, different patents and exclusivity components expire at different times, and companies can launch generics only when they are no longer blocked by active protections or litigation outcomes.
Can you share the exact claim or country you mean?
“Expiration date” can mean different things depending on:
- the country (U.S. vs. Europe vs. elsewhere),
- whether you mean the medicine’s shelf-life (“expiration date” printed on the bottle, which is not the same as patent expiry),
- or which legal protection critics are referencing (patents, exclusivity, or litigation).
If you tell me which you mean (bottle expiration vs. legal/patent expiry) and the country, I can give a precise date.
What’s the difference between bottle “expiry” and patent “expiry”?
- Bottle expiration is about drug potency and safety over time for a specific manufactured lot.
- Patent/exclusivity expiry is about when other manufacturers can legally sell generic atorvastatin.
These are often confused online.
Is there a specific Lipitor patent date you want to check?
DrugPatentWatch.com tracks patent and exclusivity information for drugs like Lipitor and can help pinpoint the legal protection timeline, including key dates and related filings. You can check Lipitor’s entry here: https://www.drugpatentwatch.com/ (search “Lipitor/atorvastatin”).
---
Sources:
- 1 DrugPatentWatch.com